Related references
Note: Only part of the references are listed.In vitro and in vivo evaluation of 211At-labeled fibroblast activation protein inhibitor for glioma treatment
Huan Ma et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2022)
An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy
Ronnie C. Mease et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer
Yawen Li et al.
NUCLEAR MEDICINE AND BIOLOGY (2021)
α-Emitting cancer therapy using 211At-AAMT targeting LAT1
Kazuko Kaneda-Nakashima et al.
CANCER SCIENCE (2021)
Microsolvation of heavy halides
Yuly Chamorro et al.
INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY (2021)
Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer
Ganesan Vaidyanathan et al.
NUCLEAR MEDICINE AND BIOLOGY (2021)
Effect of microdistribution of alpha and beta-emitters in targeted radionuclide therapies on delivered absorbed dose in a GATE model of bone marrow
Jonathan Tranel et al.
PHYSICS IN MEDICINE AND BIOLOGY (2021)
Astatine-211 labelled a small molecule peptide: specific cell killing in vitro and targeted therapy in a nude-mouse model
Weihao Liu et al.
RADIOCHIMICA ACTA (2021)
Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer
Stig Palm et al.
TRANSLATIONAL ONCOLOGY (2021)
Gold Nanostars: A Novel Platform for Developing 211At-Labeled Agents for Targeted Alpha-Particle Therapy
Yang Liu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications
Bryce J. B. Nelson et al.
PHARMACEUTICS (2021)
Radioimmunotherapy with an 211At-labeled anti-tissue factor antibody protected by sodium ascorbate
Hiroki Takashima et al.
CANCER SCIENCE (2021)
Synthesis and Preliminary Evaluation of 131I-Labeled FAPI Tracers for Cancer Theranostics
Huan Ma et al.
MOLECULAR PHARMACEUTICS (2021)
Generalization of Intrinsic Orbitals to Kramers-Paired Quaternion Spinors, Molecular Fragments, and Valence Virtual Spinors
Bruno Senjean et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2021)
Utility of 211At-Trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically Relevant Mouse Model
Huizi Keiko Li et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)
Hironori Takagi et al.
LUNG CANCER (2021)
Rapid recovery of At-211 by extraction chromatography
Jonathan D. Burns et al.
SEPARATION AND PURIFICATION TECHNOLOGY (2021)
Paradigms and paradoxes: the ionization potential of atomic astatine (Z=85), polonium (Z=84), and some other elements-what does this value tell us about the energetics of atomic and diatomic halogens
Maja Ponikvar-Svet et al.
STRUCTURAL CHEMISTRY (2021)
Extended single-dose toxicity study of [211At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer
Tadashi Watabe et al.
ANNALS OF NUCLEAR MEDICINE (2021)
Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials
Aurelie Rondon et al.
CANCERS (2021)
Simulation of the distribution of astatine-211 solution dispersion in a lab room
Hitoshi Kubo et al.
NUCLEAR MEDICINE COMMUNICATIONS (2021)
Advances in the Chemistry of Astatine and Implications for the Development of Radiopharmaceuticals
Francois Guerard et al.
ACCOUNTS OF CHEMICAL RESEARCH (2021)
211At-Labeled Polymer Nanoparticles for Targeted Radionuclide Therapy of Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR)-Overexpressed Cancer
Xiumin Shi et al.
BIOCONJUGATE CHEMISTRY (2021)
Production, purification and availability of 211At: Near term steps towards global access
Yutian Feng et al.
NUCLEAR MEDICINE AND BIOLOGY (2021)
Synthesis of [211At]4-astato-L-phenylalanine by dihydroxyboryl-astatine substitution reaction in aqueous solution
Yoshifumi Shirakami et al.
SCIENTIFIC REPORTS (2021)
Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
Hiroki Kato et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The Hopeful Eight
Romain Eychenne et al.
PHARMACEUTICS (2021)
An expanded halogen bonding scale using astatine
Lu Liu et al.
CHEMICAL SCIENCE (2021)
Addition of Astatine-211-Labeled Anti-CD45 Antibody to TBI as Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model: Radioimmunotherapy to Overcome Transfusion-Induced Sensitization
Aya Nakaya et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of Glioblastoma
Hannah Dabagian et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies
Marion Berdal et al.
CHEMICAL SCIENCE (2021)
Delocalized relativistic effects, from the viewpoint of halogen bonding
Serigne Sarr et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2021)
131I-IITM and 211At-AITM: Two Novel Small-Molecule Radiopharmaceuticals Targeting Oncoprotein Metabotropic Glutamate Receptor 1
Lin Xie et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure
Sture Lindegren et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2020)
Labeling Monoclonal Antibody with α-emitting211 At at High Activity Levels via a Tin Precursor
Ganesan Vaidyanathan et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2020)
Towards a Stronger Halogen Bond Involving Astatine: Unexpected Adduct with Bu3PO Stabilized by Hydrogen Bonding
Lu Liu et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
On the Interplay between Charge-Shift Bonding and Halogen Bonding
Serigne Sarr et al.
CHEMPHYSCHEM (2020)
Targeted α-Therapy in Cancer Management: Synopsis of Preclinical and Clinical Studies
Hossein Jadvar
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2020)
Preliminary Evaluation of Astatine-211-Labeled Bombesin Derivatives for Targeted Alpha Therapy
Miho Aoki et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2020)
A Solid-State Support for Separating Astatine-211 from Bismuth
David H. Woen et al.
INORGANIC CHEMISTRY (2020)
Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors
Tom A. Back et al.
EJNMMI RESEARCH (2020)
Targeted alpha therapy using astatine (211At)-labeled phenylalanine: A preclinical study in glioma bearing mice
Tadashi Watabe et al.
Oncotarget (2020)
Possibility of cancer-stem-cell-targeted radioimmunotherapy for acute myelogenous leukemia using 211At-CXCR4 monoclonal antibody
Noboru Oriuchi et al.
SCIENTIFIC REPORTS (2020)
Construction and Preclinical Evaluation of 211At Labeled Anti-mesothelin Antibodies as Potential Targeted Alpha Therapy Drugs
Xudong Wang et al.
JOURNAL OF RADIATION RESEARCH (2020)
The electron affinity of astatine
David Leimbach et al.
NATURE COMMUNICATIONS (2020)
Questioning the Affinity of Electrophilic Astatine for Sulfur-containing Compounds: Unexpected Bindings Revealed
Fadel Bassal et al.
INORGANIC CHEMISTRY (2020)
A simple isolation of211At using an anion-exchange spin column method
Shigeki Watanabe et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2020)
Development of high-resolution YAP(Ce) x-ray camera for the imaging of astatine-211(At-211) in small animals
Kouhei Nakanishi et al.
MEDICAL PHYSICS (2020)
Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease
Sebastien Gouard et al.
CANCERS (2020)
Preclinical evaluation of new α-radionuclide therapy targeting LAT1: 2-[211At]astato-α-methyl-L-phenylalanine in tumor-bearing model
Yasuhiro Ohshima et al.
NUCLEAR MEDICINE AND BIOLOGY (2020)
Astatine partitioning between nitric acid and conventional solvents: indication of covalency in ketone complexation of AtO+
Jonathan D. Burns et al.
CHEMICAL COMMUNICATIONS (2020)
Spin-orbit coupling is the key to unraveling intriguing features of the halogen bond involving astatine
Elisa Rossi et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2020)
Intraperitoneal α-Emitting Radioimmunotherapy with 211At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose Estimations
Andreas Hallqvist et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Enhancement of 211At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer
Tadashi Watabe et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Multifunctional Clickable Reagents for Rapid Bioorthogonal Astatination and Radio-Crosslinking
Christoph Denk et al.
CHEMPLUSCHEM (2019)
Relativistic and QED effects on NMR magnetic shielding constant of neutral and ionized atoms and diatomic molecules
Karol Koziol et al.
JOURNAL OF CHEMICAL PHYSICS (2019)
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models
Mehran Makvandi et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior
Yana Dekempeneer et al.
MOLECULAR PHARMACEUTICS (2019)
Preclinical Evaluation of the Radiotoxicity of the α-Emitting Molecular-Targeted Therapeutic Agent 211At-MABG for the Treatment of Malignant Pheochromocytoma in Normal Mice
Hitomi Sudo et al.
TRANSLATIONAL ONCOLOGY (2019)
The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model
Shyril O'Steen et al.
BLOOD (2019)
Towards elucidating the radiochemistry of astatine - Behavior in chloroform
Emma Aneheim et al.
SCIENTIFIC REPORTS (2019)
Investigation of a tellurium-packed column for isolation of astatine-211 from irradiated bismuth targets and demonstration of a semi-automated system
Yawen Li et al.
SCIENTIFIC REPORTS (2019)
Prosthetic groups for radioiodination and astatination of peptides and proteins: A comparative study of five potential bioorthogonal labeling strategies
Laurent Navarro et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Relativistic effects on the ring current strengths of the substituted borazine: B3N3H6 ( X=H, F, Cl, Br, I, At)
Walter A. Rabanal-Leon et al.
INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY (2019)
Evidence of Local Concentration of α-Particles from 211At-Labeled Antibodies in Liver Metastasis Tissue
Satoshi Kodaira et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Relativistic Effects on NMR Parameters of Halogen-Bonded Complexes
Ibon Alkorta et al.
MOLECULES (2019)
Development of an autonomous solvent extraction system to isolate astatine-211 from dissolved cyclotron bombarded bismuth targets
Matthew J. O'Hara et al.
SCIENTIFIC REPORTS (2019)
Relevance of effective bond orders in heterodiatomic molecules and role of the spin-orbit coupling in the AtX (X = At - F) series
Cecilia Gomez Pech et al.
PHYSICAL REVIEW A (2019)
An Appendix of Radionuclides Used in Targeted Alpha Therapy
Maryline G. Ferrier (Kerlin) et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES (2019)
Radiotheranostics Coupled between an At-211-Labeled RGD Peptide and the Corresponding Radioiodine-Labeled RGD Peptide
Kazuma Ogawa et al.
ACS OMEGA (2019)
Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes
Stig Palm et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Application of astatine-210: Evaluation of astatine distribution and effect of pre-injected iodide in whole body of normal rats
Hayato Ikeda et al.
APPLIED RADIATION AND ISOTOPES (2018)
Astatine-211 imaging by a Compton camera for targeted radiotherapy
Yuto Nagao et al.
APPLIED RADIATION AND ISOTOPES (2018)
Evaluation of astatine-211-labeled octreotide as a potential radiotherapeutic agent for NSCLC treatment
Bingkun Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
α-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10
Huizi Keiko Li et al.
CANCER SCIENCE (2018)
Adsorption of the astatine species on a gold surface: A relativistic density functional theory study
Yuriy Demidov et al.
CHEMICAL PHYSICS LETTERS (2018)
Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model
Yasuhiro Ohshima et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Evidence for the Heaviest Expected Halide Species in Aqueous Solution, At-, by Electromobility Measurements
Ning Guo et al.
INORGANIC CHEMISTRY (2018)
Astatine
Geerd-J Meyer
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2018)
One-step labelling of a novel small-molecule peptide with astatine-211: preliminary evaluation in vitro and in vivo
Weihao Liu et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2018)
Experimental and computational evidence of halogen bonds involving astatine
Ning Guo et al.
NATURE CHEMISTRY (2018)
Quantum calculations of At-mediated halogen bonds: on the influence of relativistic effects
N. Galland et al.
NEW JOURNAL OF CHEMISTRY (2018)
Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation
Jaeyeon Choi et al.
NUCLEAR MEDICINE AND BIOLOGY (2018)
Rapid Cu-Catalyzed [At-211]Astatination and [I-125]Iodination of Boronic Esters at Room Temperature
Sean W. Reilly et al.
ORGANIC LETTERS (2018)
Halogen-like properties of the Al13 cluster mimicking astatine
B. Molina et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2018)
Thin layer chromatography for astatine and iodine in solutions prepared by dry distillation
I. Nishinaka et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2018)
Targeted cancer cell ablation in mice by an alpha-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B
Huizi Keiko Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Equation-of-motion coupled-cluster theory based on the 4-component Dirac-Coulomb(-Gaunt) Hamiltonian. Energies for single electron detachment, attachment, and electronically excited states
Avijit Shee et al.
JOURNAL OF CHEMICAL PHYSICS (2018)
Evaluation of 209At as a theranostic isotope for 209At-radiopharmaceutical development using high-energy SPECT
J. R. Crawford et al.
PHYSICS IN MEDICINE AND BIOLOGY (2018)
The Effect of an Iodine-Free Diet on the Pharmacokinetics of the 211At Preparation
O. A. Yuminov et al.
MOSCOW UNIVERSITY PHYSICS BULLETIN (2018)
Current Consensus on I-131 MIBG Therapy
Daiki Kayano et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Microarray Studies on 211At Administration in BALB/c Nude Mice Indicate Systemic Effects on Transcriptional Regulation in Nonthyroid Tissues
Britta Langen et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with 211At-MX35-F(ab')2: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival
Tom Back et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
The bonding picture in hypervalent XF3 (X=Cl, Br, I, At) fluorides revisited with quantum chemical topology
Mohamed Amaouch et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2017)
Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer
James M. Kelly et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Radiopharmaceutical chemistry of targeted radiotherapeutics, part 4: Strategies for 211At labeling at high activities and radiation doses of 211At α-particles
Oscar R. Pozzi et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
211At labeled substance P (5-11) as potential radiopharmaceutical for glioma treatment
Monika Lyczko et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
On AunAt clusters as potential astatine carriers
Slawomir Ostrowski et al.
RSC ADVANCES (2017)
Gold nanoparticle bioconjugates labelled with 211At for targeted alpha therapy
L. Dziawer et al.
RSC ADVANCES (2017)
Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates
David Teze et al.
SCIENTIFIC REPORTS (2017)
Validating α-particle emission from 211 At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors
Satoshi Kodaira et al.
PLOS ONE (2017)
Bifunctional aryliodonium salts for highly efficient radioiodination and astatination of antibodies
F. Guerard et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Locoregional therapy with α-emitting trastuzumab against peritoneal metastasis of human epidermal growth factor receptor 2-positive gastric cancer in mice
Huizi Keiko Li et al.
CANCER SCIENCE (2017)
211Rn/211At and 209At production with intense mass separated Fr ion beams for preclinical 211At-based α-therapy research
Jason R. Crawford et al.
APPLIED RADIATION AND ISOTOPES (2017)
What can tell the quantum chemical topology on carbon-astatine bonds?
Mohamed Amaouch et al.
MOLECULAR PHYSICS (2016)
The Heaviest Possible Ternary Trihalogen Species, IAtBr-, Evidenced in Aqueous Solution: An Experimental Performance Driven by Computations
Ning Guo et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates
Emma Aneheim et al.
BIOCONJUGATE CHEMISTRY (2016)
Advances on the Determination of the Astatine Pourbaix Diagram: Predomination of AtO(OH)2- over At- in Basic Conditions
Dumitru-Claudiu Sergentu et al.
CHEMISTRY-A EUROPEAN JOURNAL (2016)
211At-labeled agents for alpha-immunotherapy: On the in vivo stability of astatine-agent bonds
Tahra Ayed et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structural, dynamical, and transport properties of the hydrated halides: How do At- bulk properties compare with those of the other halides, from F- to I-?
Florent Real et al.
JOURNAL OF CHEMICAL PHYSICS (2016)
Scrutinizing Invisible Astatine: A Challenge for Modern Density Functionals
Dumitru-Claudiu Sergentu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2016)
(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl) Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy
Ana P. Kiess et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Relativistic effects on the aromaticity of the halogenated benzenes: C6X6, X = H, F, Cl, Br, I, At
Rodrigo Ramirez-Tagle et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2016)
Silver impregnated nanoparticles of titanium dioxide as carriers for 211At
Edyta Cedrowska et al.
RADIOCHIMICA ACTA (2016)
N-12-(maleimido)ethyl]-3-(trimethylstannyl)benzamide, a molecule for radiohalogenation of proteins and peptides
Emma Aneheim et al.
APPLIED RADIATION AND ISOTOPES (2015)
Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model
Damian J. Green et al.
BLOOD (2015)
Shelf-Life of e-Lysyl-3-(Trimethylstannyl)Benzamide Immunoconjugates, Precursors for 211At Labeling of Antibodies
Emma Aneheim et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2015)
211Astatine-Conjugated Monoclonal CD45 Antibody-Based Nonmyeloablative Conditioning for Stem Cell Gene Therapy
Christopher R. Burtner et al.
HUMAN GENE THERAPY (2015)
Absorbed Doses and Risk Estimates of 211At-MX35 F(ab′)2 in Intraperitoneal Therapy of Ovarian Cancer Patients
Elin Cederkrantz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Electronic structures and geometries of the XF3 (X = Cl, Br, I, At) fluorides
Dumitru-Claudiu Sergentu et al.
JOURNAL OF CHEMICAL PHYSICS (2015)
Effective bond orders from two-step spin-orbit coupling approaches: The I2, At2, IO+, and AtO+ case studies
Remi Maurice et al.
JOURNAL OF CHEMICAL PHYSICS (2015)
α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After 211At-Radioimmunotherapy for Hematopoietic Cell Transplantation
Sofia H. L. Frost et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Stability and in vivo behavior of Rh[16aneS4-diol]211At complex: A potential precursor for astatine radiopharmaceuticals
Marek Pruszynski et al.
NUCLEAR MEDICINE AND BIOLOGY (2015)
Ionization potentials and electron affinities of the superheavy elements 115-117 and their sixth-row homologues Bi, Po, and At
A. Borschevsky et al.
PHYSICAL REVIEW A (2015)
Automated astatination of biomolecules - a stepping stone towards multicenter clinical trials
Emma Aneheim et al.
SCIENTIFIC REPORTS (2015)
Transcriptional response in normal mouse tissues after i.v. 211At administration - response related to absorbed dose, dose rate, and time
Britta Langen et al.
EJNMMI RESEARCH (2015)
Astatine-211 labeling: a study towards automatic production of astatinated antibodies
Emma Aneheim et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2015)
Transcriptional Response in Mouse Thyroid Tissue after 211At Administration: Effects of Absorbed Dose, Initial Dose-Rate and Time after Administration
Nils Rudqvist et al.
PLOS ONE (2015)
Sequential Radioimmunotherapy with 177Lu-and 211At-Labeled Monoclonal Antibody BR96 in a Syngeneic Rat Colon Carcinoma Model
Sophie E. Eriksson et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2014)
QTAIM Analysis in the Context of Quasirelativistic Quantum Calculations
Julien Pilme et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2014)
The Advantage of Antibody Cocktails for Targeted Alpha Therapy Depends on Specific Activity
Jordan B. Pasternack et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Electronic structure investigation of the evanescent AtO+ ion
Andre Severo Pereira Gomes et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2014)
Radioiodinated and astatinated NHC rhodium complexes: Synthesis
Holisoa Rajerison et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model
Johnnie J. Orozco et al.
BLOOD (2013)
Comparison of 211At-PRIT and 211At-RIT of Ovarian Microtumors in a Nude Mouse Model
Sofia H. L. Frost et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Production of [211At]-Astatinated Radiopharmaceuticals and Applications in Targeted α-Particle Therapy
Francois Guerard et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Biodistribution and Dosimetry of Free 211At, 125I- and 131I- in Rats
Johan Spetz et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Theoretical Insights into the Nature of Halogen Bonding in Prereactive Complexes
J. Grant Hill et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Differential gene expression in human fibroblasts after alpha-particle emitter 211At compared with 60Co irradiation
Anna Danielsson et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2013)
Which Elements Are Metalloids?
Rene E. Vernon
JOURNAL OF CHEMICAL EDUCATION (2013)
Communication: Two-component ring-coupled-cluster computation of the correlation energy in the random-phase approximation
Katharina Krause et al.
JOURNAL OF CHEMICAL PHYSICS (2013)
Comparative Analysis of Transcriptional Gene Regulation Indicates Similar Physiologic Response in Mouse Tissues at Low Absorbed Doses from Intravenously Administered 211At
Britta Langen et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Ex Vivo Activity Quantification in Micrometastases at the Cellular Scale Using the α-Camera Technique
Nicolas Chouin et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Investigation of Astatine(III) Hydrolyzed Species: Experiments and Relativistic Calculations
Julie Champion et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2013)
How Does the Solvation Unveil AtO+ Reactivity?
Tahra Ayed et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
Rationalization of the Solvation Effects on the AtO+ Ground-State Change
Tahra Ayed et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
Enigmatic astatine
D. Scott Wilbur
NATURE CHEMISTRY (2013)
Systemic treatment with 4-211At-phenylalanine enhances survival of rats with intracranial glioblastoma
N. Borrmann et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2013)
Condensed Astatine: Monatomic and Metallic
Andreas Hermann et al.
PHYSICAL REVIEW LETTERS (2013)
Definition of the halogen bond (IUPAC Recommendations 2013)
Gautam R. Desiraju et al.
PURE AND APPLIED CHEMISTRY (2013)
Measurement of the first ionization potential of astatine by laser ionization spectroscopy
S. Rothe et al.
NATURE COMMUNICATIONS (2013)
Successful radioimmunotherapy of established syngeneic rat colon carcinoma with 211 At-mAb
Sophie E. Eriksson et al.
EJNMMI RESEARCH (2013)
Reagents for Astatination of Biomolecules. 6. An Intact Antibody Conjugated with a Maleimido-closo-Decaborate(2-) Reagent via Sulfhydryl Groups Had Considerably Higher Kidney Concentrations than the Same Antibody Conjugated with an Isothiocyanato-closo-Decaborate(2-) Reagent via Lysine Amines
D. Scott Wilbur et al.
BIOCONJUGATE CHEMISTRY (2012)
Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation
Yun Chen et al.
BLOOD (2012)
Evaluation of Effects on the Peritoneum After Intraperitoneal α-Radioimmunotherapy with 211At
Elin Cederkrantz et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2012)
Structures and stabilities of group 17 fluorides EF3 (E = I, At, and element 117) with spin-orbit coupling
Dong-Dong Yang et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2012)
Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model
Anna M. E. Gustafsson et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Give me a fulcrum in space, and I lift my world upside down
J. Kotzerke et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2012)
Transcriptional response of BALB/c mouse thyroids following in vivo astatine-211 exposure reveals distinct gene expression profiles
Nils Rudqvist et al.
EJNMMI RESEARCH (2012)
Reagents for Astatination of Biomolecules. 5. Evaluation of Hydrazone Linkers in 211At- and 125I-Labeled closo-Decaborate(2-) Conjugates of Fab′ as a Means of Decreasing Kidney Retention
D. Scott Wilbur et al.
BIOCONJUGATE CHEMISTRY (2011)
In Vivo Distribution of Avidin-Conjugated MX35 and 211At-Labeled, Biotinylated Poly-L-Lysine for Pretargeted Intraperitoneal α-Radioimmunotherapy
Sofia Helena Linnea Frost et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2011)
Is Electronegativity a Useful Descriptor for the Pseudo-Alkali Metal NH4?
Alexander Whiteside et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
RBE of α-particles from 211At for complex DNA damage and cell survival in relation to cell cycle position
Kristina Claesson et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2011)
Astatine-211 labeling of protein using TCP as a bi-functional linker: synthesis and preliminary evaluation in vivo and in vitro
Yuanyou Yang et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2011)
Assessment of an effective quasirelativistic methodology designed to study astatine chemistry in aqueous solution
Julie Champion et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2011)
Effect of cetuximab in combination with alpha-radioimmunotherapy in cultured squamous cell carcinomas
Marika Nestor et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
At-211-AntiCD33 in NMRl nu/nu mice - Biodistribution, in vivo stability
A. Walte et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2011)
Adsorption interaction of astatine species with quartz and gold surfaces
A. Serov et al.
RADIOCHIMICA ACTA (2011)
Synthesis and analysis of 2-[211At]-L-phenylalanine and 4-[211At]-L-phenylalanine and their uptake in human glioma cell cultures in-vitro
Geerd J. Meyer et al.
APPLIED RADIATION AND ISOTOPES (2010)
In Vitro Evaluation of Avidin Antibody Pretargeting Using 211At-Labeled and Biotinylated Poly-L-Lysine as Effector Molecule
Sofia H. L. Frost et al.
CANCER (2010)
In vitro experimental At-211-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicin
Thorsten Petrich et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Ionization Potentials, Electron Affinities, Resonance Excitation Energies, Oscillator Strengths, And Ionic Radii of Element Uus (Z=117) and Astatine
Zhiwei Chang et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2010)
Astatine Standard Redox Potentials and Speciation in Acidic Medium
J. Champion et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2010)
Preparation and in vivo evaluation of radioiodinated closo-decaborate(2-) derivatives to identify structural components that provide low retention in tissues
D. Scott Wilbur et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Gene Expression Profile of Human Lymphocytes Exposed to 211At α Particles
A. Turtoi et al.
RADIATION RESEARCH (2010)
Cancer Therapy with Alpha-Emitters Labeled Peptides
Ekaterina Dadachova
SEMINARS IN NUCLEAR MEDICINE (2010)
Reagents for Astatination of Biomolecules. 3. Comparison of closo-Decaborate(2-) and closo-Dodecaborate(2-) Moieties as Reactive Groups for Labeling with Astatine-211
D. Scott Wilbur et al.
BIOCONJUGATE CHEMISTRY (2009)
Reagents for Astatination of Biomolecules. 4. Comparison of Maleimido-closo-Decaborate(2-) and meta-[211At]Astatobenzoate Conjugates for Labeling anti-CD45 Antibodies with [211At]Astatine
D. Scott Wilbur et al.
BIOCONJUGATE CHEMISTRY (2009)
Intraperitoneal Alpha-Radioimmunotherapy in Mice Using Different Specific Activities
Jorgen Elgqvist et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Glomerular Filtration Rate After Alpha-Radioimmunotherapy with 211At-MX35-F(ab′)2: A Long-Term Study of Renal Function in Nude Mice
Tom Back et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211
Hirohisa Nakamae et al.
CANCER RESEARCH (2009)
Determination of stability constants between complexing agents and At(I) and At(III) species present at ultra-trace concentrations
J. Champion et al.
INORGANICA CHIMICA ACTA (2009)
Effect of At-211 alpha-particle irradiation on expression of selected radiation responsive genes in human lymphocytes
Andrei Turtoi et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2009)
Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab′)2-A Phase I Study
Hakan Andersson et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Radiation-Induced Thyroid Stunning: Differential Effects of 123I, 131I, 99mTc, and 211At on Iodide Transport and NIS mRNA Expression in Cultured Thyroid Cells
Charlotta Lundh et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of α-particle-emitting 211At-labeled trastuzumab
Abraham Boskovitz et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Streptavidin in antibody pretargeting. 5. Chemical modification of recombinant streptavidin for labeling with the alpha-particle-emitting radionuclides Bi-213 and At-211
D. Scott Wilbur et al.
BIOCONJUGATE CHEMISTRY (2008)
Preparation of Rh[16aneS4-diol]211At and Ir[16aneS4-diol]211At complexes as potential precursors for astatine radiopharmaceuticals.: Part I:: Synthesis
Marek Pruszynski et al.
BIOCONJUGATE CHEMISTRY (2008)
Effective treatment of established human breast tumor xenografts in immunodeficient mice with a single dose of the α-emitting radioisotope astatine-211 conjugated to anti-HER2/neu diabodies
Matthew K. Robinson et al.
CLINICAL CANCER RESEARCH (2008)
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer
Michael J. Willhauck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Engineered modular recombinant transporters:: Application of new platform for targeted radiotherapeutic agents to α-particle emitting 211At
Andrey A. Rosenkranz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Variational and diffusion Monte Carlo study of post-d group 13-17 elements
W. A. Al-Saidi
JOURNAL OF CHEMICAL PHYSICS (2008)
Direct procedure for the production of 211At-labeled antibodies with an ε-lysyl-3-(trimethylstannyl)benzamide immunoconjugate
Sture Lindegren et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Competition of Hydrogen Bonds and Halogen Bonds in Complexes of Hypohalous Acids with Nitrogenated Bases
Ibon Alkorta et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2008)
Spin-Orbit and Electron Correlation Effects on the Structure of EF3 (E = I, At, and Element 117)
Hyoseok Kim et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2008)
Clinical experience with alpha-particle-emitting At-211: Treatment of recurrent brain tumor patients with At-211-labeled chimeric antitenascin monoclonal antibody 81C6
Michael R. Zalutsky et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice
Stig Palm et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
211AtCl@US-Tube nanocapsules:: A new concept in radiotherapeutic-agent design
Keith B. Hartman et al.
SMALL (2007)
Biodistribution of 211At-Labeled humanized monoclonal antibody A33
Ylva Almqvist et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2007)
Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination
D. Scott Wilbur et al.
BIOCONJUGATE CHEMISTRY (2007)
Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 3:: α-particle-induced radiolytic effects on the chemical behaviour of 211At
Oscar R. Pozzi et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Transport of free 211At and 125I- in thyroid epithelial cells:: effects of anion channel blocker 4,4′-diisothlocyanostilbene-2,2′-disulfonic acid on apical efflux and cellular retention
Ulrika Lindencrona et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma
Junping Cheng et al.
LARYNGOSCOPE (2007)
A kit method for the high level synthesis of [211At]MABG
Ganesan Vaidyanathan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Astatine-211 labeling of insulin: Synthesis and preliminary evaluation in vivo and in vitro
Ning Liu et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2007)
Relative biological effectiveness of the α-particle emitter 211At for double-strand break induction in human fibroblasts
Anna Kristina Claesson et al.
RADIATION RESEARCH (2007)
A tin precursor for the synthesis of no-carrier-added [*I]MIBG and [211At]MABG
Ganesan Vaidyanathan et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2007)
Enhancing the effect of radionuclide tumor targeting, using lysosomotropic weak bases
Asa Liljegren Sundberg et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Biodistribution of free 211At and 125I- in nude mice bearing tumors derived from anaplastic thyroid carcinoma cell lines
Charlotta Lundh et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2006)
Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab′)2
Jorgen Elgqvist et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Fractionated radio immunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab′)2:: therapeutic efficacy and myelotoxicity
Jorgen Elgqvist et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
The anti-CD25 monoclonal antibody 7G7/B6, armed with the α-emitter 211At, provides effective radioimmunotherapy for a murine model of leukemia
Meili Zhang et al.
CANCER RESEARCH (2006)
Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25
Zhuo Zhang et al.
BLOOD (2006)
Preparation and in vivo evaluation of a novel stabilized linker for 211At labeling of protein
Vladimir S. Talanov et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
In vitro cytotoxicity of 211At-labeled trastuzumab in human breast cancer cell lines:: effect of specific activity and HER2 receptor heterogeneity on survival fraction
G Akabani et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
Effective cancer therapy with the α-particle emitter [211At]astatine in a mouse model of genetically modified sodium/iodide symporter-expressing tumors
T Petrich et al.
CLINICAL CANCER RESEARCH (2006)
Astatination of nanoparticles containing silver as possible carriers of 211At
J Kucka et al.
APPLIED RADIATION AND ISOTOPES (2006)
Synthesis and evaluation of glycosylated octreotate analogues labeled with radioiodine and At-211 via a tin precursor
G Vaidyanathan et al.
BIOCONJUGATE CHEMISTRY (2006)
In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma
M Nestor et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
In vitro characterization of 211At-labeled antibody A33 -: a potential therapeutic agent against metastatic colorectal carcinoma
Y Almqvist et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2005)
Adsorption and volatility of free 221At and 125I-
U Lindencrona et al.
APPLIED RADIATION AND ISOTOPES (2005)
Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the α-emitting radionuclides 212Bi or 211At
JN Wesley et al.
NUCLEAR MEDICINE AND BIOLOGY (2004)
Microdosimetry of astatine-211 single-cell irradiation: Role of daughter polonium-211 diffusion
S Palm et al.
MEDICAL PHYSICS (2004)
An efficient targeted radiotherapy/gene therapy strategy utilising human tetomerase promoters and radioastatine and harnessing radiation-mediated bystander effects
M Boyd et al.
JOURNAL OF GENE MEDICINE (2004)
Radioiodine and 211At-labeled guanidinomethyl halobenzoyl octreotate conjugates:: potential peptide radiotherapeutics for somatostatin receptor-positive cancers
G Vaidyanathan et al.
PEPTIDES (2004)
Preparation and in vivo evaluation of novel linkers for 211At labeling of proteins
VS Talanov et al.
NUCLEAR MEDICINE AND BIOLOGY (2004)
The Na+/I- symporter (NIS): Imaging and therapeutic applications
E Dadachova et al.
SEMINARS IN NUCLEAR MEDICINE (2004)
Biotin reagents in antibody pretargeting.: 6.: Synthesis and in vivo evaluation of astatinated and radioiodinated aryl- and nido-carboranyl-biotin derivatives
DS Wilbur et al.
BIOCONJUGATE CHEMISTRY (2004)
Reagents for astatination of biomolecules: Comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds
DS Wilbur et al.
BIOCONJUGATE CHEMISTRY (2004)
Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF
ÅL Sundberg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate:: an acylation agent for labeling internalizing antibodies with α-particle emitting 21At
G Vaidyanathan et al.
NUCLEAR MEDICINE AND BIOLOGY (2003)
Treatment of cultured glioma cells with the EGFR-TKI gefitinib (Iressa, ZD1839) increases the uptake of astatinated EGF despite the absence of gefitinib-mediated growth inhibition
AL Sundberg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Spin-orbit and relativistic effects on structures and stabilities of group 17 fluorides EF3 (E = I, At, and element 117):: Relativity induced stability for the D3h structure of (117)F3
C Bae et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2003)
Direct astatination of a tumour-binding protein, human epidermal growth factor, using nido-carborane as a prosthetic group
A Sjostrom et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2003)
Some microdosmetric data on Astatine-211
T Unak
APPLIED RADIATION AND ISOTOPES (2003)
Vascular targeted endoradiotherapy of tumors using alpha-particle-emitting compounds: Theoretical analysis
G Akabani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Sodium-iodide symporter (NIS)-mediated accumulation of [211AT]astatide in NIS-transfected human cancer cells
S Carlin et al.
NUCLEAR MEDICINE AND BIOLOGY (2002)
Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter
T Petrich et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Radiation doses to non-Hodgkin's lymphoma cells and normal bone marrow exposed in vitro.: Comparison of an α-emitting radioimmunoconjugate and external γ-irradiation
E Aurlien et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2002)
Preparation and in vivo evaluation of linkers for 211At labeling of humanized anti-Tac
AT Yordanov et al.
NUCLEAR MEDICINE AND BIOLOGY (2001)
Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin
S Demartis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
High-efficiency astatination of antibodies using N-iodosuccinimide as the oxidising agent in labelling of N-succinimidyl 3-(trimethylstannyl)benzoate
S Lindegren et al.
NUCLEAR MEDICINE AND BIOLOGY (2001)
Similarities and differences between free At-211 and I-125(-) transport in porcine thyroid epithelial cells cultured in bicameral chambers
U Lindencrona et al.
NUCLEAR MEDICINE AND BIOLOGY (2001)
At-211 labeling of a monoclonal antibody and its Fab fragment: Cytotoxicity on human gastric cancer cells and biodistribution in nude mice with tumor xenografts
N Liu et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2001)
Demonstration of highly specific toxicity of the α-emitting radioimmunoconjugate 211At-rituximab against non-Hodgkins lymphoma cells
E Aurlien et al.
BRITISH JOURNAL OF CANCER (2000)
Radioiodination and astatination of octreotide by conjugation labeling
G Vaidyanathan et al.
NUCLEAR MEDICINE AND BIOLOGY (2000)
Astatine-211-labeled radiotherapeutics: An emerging approach to targeted alpha-particle radiotherapy
MR Zalutsky et al.
CURRENT PHARMACEUTICAL DESIGN (2000)
Share Paper
